Showing results (201-210 of 220) with videos related to

Sort By:
Pageof 22
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 17, 2011
Degree of freezing does not affect efficacy of frozen gloves for prevention of docetaxel-induced nail toxicity in breast cancer patientsH Ishiguro, S Takashima, K Yoshimura, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 10, 2012
The sequential use of endocrine treatment for advanced breast cancer: where are we?C Barrios, J F Forbes, W Jonat, et al.
The Cancer Journal From Scientific American|April 13, 1999
Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapyG Gasparini, M Toi, R Miceli, et al.
Cancer Research|December 5, 2000
Somatic mutations of LKB1 and beta-catenin genes in gastrointestinal polyps from patients with Peutz-Jeghers syndromeM Miyaki, T Iijima, K Hosono, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 15, 2016
Clinical benefit of nomogram for predicting positive resection margins in breast conserving surgeryE-S Lee, W Han, H-C Shin, et al.
British Journal of Cancer|October 22, 2009
Lapatinib monotherapy in patients with relapsed, advanced, or metastatic breast cancer: efficacy, safety, and biomarker results from Japanese patients phase II studiesM Toi, H Iwata, Y Fujiwara, et al.
Scientific Reports|February 8, 2017
Visualization of tumor-related blood vessels in human breast by photoacoustic imaging system with a hemispherical detector arrayM Toi, Y Asao, Y Matsumoto, et al.
Breast Cancer Research and Treatment|March 25, 2017
Outcomes of fulvestrant therapy among japanese women with advanced breast cancer: a retrospective multicenter cohort study (JBCRG-C06; Safari)H Kawaguchi, N Masuda, T Nakayama, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2016
Final efficacy and updated safety results of the randomized phase III BEATRICE trial evaluating adjuvant bevacizumab-containing therapy in triple-negative early breast cancerR Bell, J Brown, M Parmar, et al.
The Pharmacogenomics Journal|August 9, 2017
Characterisation of the HLA-DRB1*07:01 biomarker for lapatinib-induced liver toxicity during treatment of early-stage breast cancer patients with lapatinib in combination with trastuzumab and/or taxanesC F Spraggs, L R Parham, L P Briley, et al.
Pageof 22